IFN-γ-诱导肠上皮细胞类型特异性编程细胞死亡:PANoptosis及其在克罗恩病中的调节
Chansu Lee1,2, Ji Eun Kim1, Yeo-Eun Cha1,2
1Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Frontiers in immunology
|April 15, 2025
概括
干扰素- (IFN-γ) 在克罗恩病 (CD) 患者的肠道细胞中触发编程细胞死亡 (PANoptosis). 一种JAK1抑制剂有效地阻止了这种反应,为CD提供了潜在的治疗策略.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 克罗恩病 (Crohn's disease,简称CD) 是一种慢性炎症性肠病 (IBD),其特征是Th1介导的炎症.
- 干扰素- (IFN-γ) 在CD中过度表达,并影响肠道上皮细胞 (IECs).
研究的目的:
- 研究IFN-γ对IECs的影响,特别关注编程细胞死亡 (PCD) 途径.
- 评估CD中IFN-γ诱导反应的潜在治疗点.
主要方法:
- 来自健康对照组和CD患者的确定的人类小肠器官 (enteroids).
- 评估了IFN-γ诱导的PCD途径,包括热,光和死.
- 在患者组织和单细胞RNA测序数据中验证的发现.
主要成果:
- 在IEC中由IFN-γ诱导的剂量依赖的PANoptosis来自对照和CD体.
- 观察到肠细胞枯竭和杯状细胞扩张,与差异性的PANoptosis基因表达.
- 一种选择性JAK1抑制剂 (upadacitinib) 阻止了IFN-γ诱导的细胞毒性和PANoptosis.
- 在CD患者的组织中,PANoptosis被显著激活.
结论:
- IFN-γ在肠道肠细胞中诱导PANoptosis,这是克罗恩氏病发病的一个关键过程.
- 选择性JAK1抑制是一种有前途的治疗方法,用于控制CD中的IFN-γ驱动炎症.
相关概念视频
The Extrinsic Apoptotic Pathway
5.5K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
5.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.0K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
105
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
105
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
100
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
100
Inflammatory Bowel Disease I: Ulcerative Colitis
98
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
98
Inflammatory Bowel Disease II: Crohn's Disease
129
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
129


